Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | MINA |
| Gene Name: | MINA |
| Protein Full Name: | MYC-induced nuclear antigen |
| Alias: | Mineral dust-induced gene protein; Nucleolar protein 52 |
| Mass (Da): | 52800 |
| Number AA: | 465 |
| UniProt ID: | Q8IUF8 |
| Locus ID: | 84864 |
| COSMIC ID: | MINA |
| Gene location on chromosome: | 3q11.2 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 0.35 |
| Normal role description: | MINA is activated by the myc oncogene and is a downstream target of the MYC pathway. Also involved in ribosome synthesis. Overall, MINA expression increases cell proliferation. Upregulated in numerous cancer systems. |